Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Third-Party Coordination Of Medicare Rx Benefits Is Focus Of CMS Request

This article was originally published in The Pink Sheet Daily

Executive Summary

Centers for Medicare & Medicaid Services’ request for proposals seeks a contractor to assist in “coordinating benefits and facilitating an accurate accounting of a beneficiary’s true out-of-pocket spending,” Administrator McClellan tells Senate Special Committee on Aging.

You may also be interested in...



Medicare Rx Benefits System Contract Awarded To NDCHealth

Under the contract, NDCHealth will coordinate beneficiary coverage between prescription drug plans and entities other than Medicare. The one-year contact is valued at $416,700 with three one-year extensions; it also includes up to $3.9 mil. for processing transactions during a single year.

Medicare Rx Benefits System Contract Awarded To NDCHealth

Under the contract, NDCHealth will coordinate beneficiary coverage between prescription drug plans and entities other than Medicare. The one-year contact is valued at $416,700 with three one-year extensions; it also includes up to $3.9 mil. for processing transactions during a single year.

Medicare Part D Corrections Bill Would Be “Tall Order” For ’05 – Sen. Smith

A Medicare Part D corrections bill is unlikely to move through Congress before the implementation of the benefit, Senate Special Committee on Aging Chairman Gordon Smith (R-Ore.) said March 3

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS061872

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel